GHISLAINE MAXWELL - OAP ifID ACCT. For die Period 3/1/14 to 3/31/14 Equity Summary Asset Categories Beginning Ending Change Current Market Value Market Value In Value Allocation EAFE Equity 137,528.10 0.00 (137,528.10) Equity Detail Pnce Quantity Value Adjusted Tax Cost Unrealized Gain/Loss Est. Annual Inc. Yield Original Cost Accrued Div. EA FE Equity GLAXOSMITHKLINE PLC 53.43 0.00 4.62% SPONS ADR 684.77 37733W-10-5 GSK KIRIN HOLDINGS COMPANY LTD 13.85 0.00 2.00% SPONS ADR 476.23 497350-30-6 KNBW FtECKITT BENCKISER GROUP PLC 16.48 0.00 2.57% SPONSORED ADR 776.95 756255-20-4 RBGL Total WE Equity $0.00 S0.00 $0.00 $0.00 0.00% $1.937.95 JP Morgan Page 3 of 7 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00046778 SDNY_GM_00315976 EFTA01519491